Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Licata

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Journal of Viral Hepatitis|February 10, 2009
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infectionG Tarantino, V D Marco, S Petta, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Medical Oncology (Northwood, London, England)|April 29, 2006
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasiasS G Thakkar, C Isada, J Smith, et al.
The American Journal of Medicine|December 1, 1993
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapyS T Harris, N B Watts, R D Jackson, et al.
JAMA|February 15, 2001
Risk of new vertebral fracture in the year following a fractureR Lindsay, S L Silverman, C Cooper, et al.
Journal of Translational Medicine|February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumorSteven C Katz, Rachel A Burga, Seema Naheed, et al.
Clinical Therapeutics|February 24, 2001
Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptomsP D Miller, G Woodson, A A Licata, et al.
The American Journal of Gastroenterology|December 20, 2017
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER StudyS Basili, V Raparelli, L Napoleone, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Diagnosis of Tuberculosis in a Case of Chronic Urticaria following Omalizumab TherapyAlberto Zolezzi, Gina Gualano, Maria A Licata, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2008
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systemsC Cammà, V Di Marco, G Cabibbo, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Journal of Viral Hepatitis|February 10, 2009
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infectionG Tarantino, V D Marco, S Petta, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Medical Oncology (Northwood, London, England)|April 29, 2006
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasiasS G Thakkar, C Isada, J Smith, et al.
The American Journal of Medicine|December 1, 1993
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapyS T Harris, N B Watts, R D Jackson, et al.
JAMA|February 15, 2001
Risk of new vertebral fracture in the year following a fractureR Lindsay, S L Silverman, C Cooper, et al.
Journal of Translational Medicine|February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumorSteven C Katz, Rachel A Burga, Seema Naheed, et al.
Clinical Therapeutics|February 24, 2001
Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptomsP D Miller, G Woodson, A A Licata, et al.
The American Journal of Gastroenterology|December 20, 2017
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER StudyS Basili, V Raparelli, L Napoleone, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Diagnosis of Tuberculosis in a Case of Chronic Urticaria following Omalizumab TherapyAlberto Zolezzi, Gina Gualano, Maria A Licata, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2008
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systemsC Cammà, V Di Marco, G Cabibbo, et al.
Pageof 22